In part 3 of this interview with Dermatology Times, Adam Friedman, MD, FAAD, professor and chair of dermatology at the George Washington University School of Medicine and Health Sciences, emphasized the urgent need for industry involvement, organized advocacy, and collaborative action to improve outcomes for patients with lichen planus.
This latest discussion builds on prior conversations: Part 1, which spotlighted screening practices and disparities in care; and part 2, which focused on therapeutic trends and treatment gaps based on findings from a large cross-sectional survey of more than 400 dermatology clinicians. Click here to watch the full interview.